Clinical Trial: A Study of DCR-STAT3 in Adults With Solid Tumors
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Solid Tumor, Adult
Study Type: INTERVENTIONAL
Official Title: An Open-label, Phase 1, Dose-ranging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous DCR-STAT3 in Adults With Refractory Solid Tumors
Brief Summary:
This is a sequential, ascending-dose, multicenter study conducted in patients with refractory solid tumors designed to evaluate the safety, tolerability, and pharmacokinetics of DCR-STAT3.
Read more